Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. [electronic resource]
Producer: 20181004Description: 303-311 p. digitalISSN:- 1179-1942
- Cholesterol, LDL -- metabolism
- Enzyme Inhibitors -- adverse effects
- Female
- Genotype
- Humans
- Hypercholesterolemia -- drug therapy
- Male
- PCSK9 Inhibitors
- Phenotype
- Polymorphism, Single Nucleotide -- genetics
- Product Surveillance, Postmarketing -- methods
- Risk Factors
- Spinal Dysraphism -- chemically induced
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.